Day care and treatment

The United States approves the use of Aducanumab: a treatment for Alzheimer's disease

Ace Alzheimer Center Barcelona participated in Biogen's clinical trial for the drug Aducanumab. During the clinical trial, we were the sixth center that was able to include the most people in the study worldwide and the first in Europe.

Vaccination begins in the Day care Unit

Monday, March 1, the vaccination of the users of the Day care Center and Day care Hospital of Fundació ACE began. Three teams of nurses from the Hospital Clínic (Barcelona) have administered the first dose of the Pfizer vaccine to the users of the Day Car

Fundació ACE’s Board appoints Miren Jone Gurrutxaga as new General Director

The hitherto director of economic and human resources management at Fundació ACE takes on the challenge of leading an institution that has experienced notable growth in recent years.

We celebrate the International Day of Women and Girls in Science

At Fundació ACE we have 46 female researchers, neurologists, neuropsychologists and nurses who develop their professional activity in the Diagnostic Unit, clinical trials and applied, genomic, clinical and social research.

Fundació ACE publishes the largest number of scientific publications of its history during the pandemic

During the pandemic, our research team has published 41 articles that bring different advances in the knowledge of dementias and Alzheimer's. It represents 52% more articles compared to 2019, thus achieving the historical record of publications.

The Day Care Unit applies successful anti-COVID measures

02/02/2021Day care and treatment
Fundació ACE’s Day Care Unit, formed by the Day Centre, the Day Hospital and the Memory Workshops, ends the year 2020 without COVID-19 infections in their centres.